| Insulin resistance–related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes … TJ Orchard, JC Olson, JR Erbey, K Williams, KYZ Forrest, ... Diabetes care 26 (5), 1374-1379, 2003 | 643 | 2003 |
| Can clinical factors estimate insulin resistance in type 1 diabetes? KV Williams, JR Erbey, D Becker, S Arslanian, TJ Orchard Diabetes 49 (4), 626-632, 2000 | 586 | 2000 |
| The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes KV Williams, ML Mullen, DE Kelley, RR Wing Diabetes care 21 (1), 2-8, 1998 | 284 | 1998 |
| Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? KV Williams, S Nayak, D Becker, J Reyes, LA Burmeister The Journal of Clinical Endocrinology & Metabolism 82 (6), 1727-1733, 1997 | 244 | 1997 |
| Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus DE Kelley, KV Williams, JC Price, TM McKolanis, BH Goodpaster, ... The Journal of Clinical Endocrinology & Metabolism 86 (11), 5412-5419, 2001 | 157 | 2001 |
| Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity MF Muldoon, RH Mackey, KV Williams, MT Korytkowski, JD Flory, ... The journal of clinical Endocrinology & metabolism 89 (1), 266-271, 2004 | 155 | 2004 |
| Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes JC Olson, JR Erbey, KYZ Forrest, K Williams, DJ Becker, TJ Orchard Metabolism-Clinical and Experimental 51 (2), 248-254, 2002 | 110 | 2002 |
| Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes. KV Williams, DE Kelley Diabetes, obesity & metabolism 2 (3), 2000 | 101 | 2000 |
| Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study. KV Williams, JR Erbey, D Becker, TJ Orchard Diabetes care 22 (7), 1084-1091, 1999 | 91 | 1999 |
| Subclinical atherosclerosis and estimated glucose disposal rate as predictors of mortality in type 1 diabetes JC Olson, JR Erbey, KV Williams, DJ Becker, D Edmundowicz, SF Kelsey, ... Annals of epidemiology 12 (5), 331-337, 2002 | 81 | 2002 |
| Insulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by PET DE Kelley, KV Williams, JC Price American Journal of Physiology-Endocrinology and Metabolism 277 (2), E361-E369, 1999 | 78 | 1999 |
| Influence of Pro12Ala peroxisome proliferator-activated receptor γ2 polymorphism on glucose response to exercise training in type 2 diabetes KB Adamo, RJ Sigal, K Williams, G Kenny, D Prud’homme, F Tesson Diabetologia 48, 1503-1509, 2005 | 71 | 2005 |
| Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography KV Williams, JC Price, DE Kelley Diabetes 50 (9), 2069-2079, 2001 | 71 | 2001 |
| Determination of the lumped constant for [18F] fluorodeoxyglucose in human skeletal muscle DE Kelley, KV Williams, JC Price, B Goodpaster Journal of Nuclear Medicine 40 (11), 1798-1804, 1999 | 59 | 1999 |
| Weight loss-induced plasticity of glucose transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes KV Williams, A Bertoldo, P Kinahan, C Cobelli, DE Kelley Diabetes 52 (7), 1619-1626, 2003 | 49 | 2003 |
| Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model KV Williams, A Bertoldo, B Mattioni, JC Price, C Cobelli, DE Kelley The Journal of Clinical Endocrinology & Metabolism 88 (3), 1271-1279, 2003 | 44 | 2003 |
| Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration KV Williams, DJ Becker, TJ Orchard, T Costacou Journal of Diabetes and its Complications 33 (9), 657-661, 2019 | 23 | 2019 |
| Weight loss and leptin changes in individuals with type 2 diabetes KV Williams, M Mullen, W Lang, RV Considine, RR Wing Obesity research 7 (2), 155-163, 1999 | 23 | 1999 |
| Risk factors for the development of retinopathy in prediabetes and type 2 diabetes: the diabetes prevention program experience NH White, Q Pan, WC Knowler, EB Schroeder, D Dabelea, EY Chew, ... Diabetes care 45 (11), 2653-2661, 2022 | 19 | 2022 |
| A randomized controlled trial of antibody response to 2019–20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults KV Williams, B Zhai, JF Alcorn, MP Nowalk, MZ Levine, SS Kim, ... Vaccine 40 (5), 780-788, 2022 | 13 | 2022 |
